All Posts

With demand for GLP-1 medications like semaglutide and tirzepatide soaring, clinical trials have quietly become one of the only ways some people can access treatment, especially if they’re uninsured or can’t afford retail prices. But before you go signing up for an experimental dose of the next Ozempic or peptide agonist, there are a few important things to understand. In this article, we'll talk about what clinical trials are, their pros and cons, what to expect, and how to

Retatrutide is being called the “triple threat” of weight loss drugs—and it’s not even on the market yet. Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster.

What I found was both wild and well-documented: the gut—yes, your gut—may be deeply involved in how osteoarthritis develops and how it could be treated. A hormone called GLP-1, best known for regulating digestion and appetite, might also protect cartilage and reduce joint inflammation. Researchers call it the gut-joint axis, and it’s changing the way we think about osteoarthritis.

If you're on a GLP-1 diet—whether it’s Ozempic, Wegovy, Mounjaro, Zepbound, or any of the others—you’ve probably heard some chatter about magnesium. But before you grab just any bottle off the shelf, there’s something you should know: not all magnesium supplements are created equal. Picking the wrong type can make your symptoms worse—or just do nothing at all.

The window for GLP-1 compounders to tap dance around the compounding ban is almost closed — and anyone still trying to squeeze through could end up with some bruised fingers. A federal court ruling has backed the FDA’s determination that shortages of Wegovy and Ozempic are officially over, setting up a sharp end to the era of legally available compounded GLP-1s.

File it under "you know someone is true friend when," category, but when the infamous sulphur burps of a GLP-1 diet hit me, I had to know...

Starting a GLP-1 journey can feel overwhelming — not just because of the medication, but because of the new language that comes with it....

Women make up the majority of GLP-1 users, meaning they take medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro,...

GLP-1 medications are poised to be a $125 billion industry by 2030, and that has a lot of people wondering how to get the same boost you can get in drugs like Ozempic and Zepbound naturally.

Losing a lot of weight — whether through lifestyle changes, medication like GLP-1s, or surgery — often brings an unexpected side effect:...

If you found your way to this article, you're likely wondering "Am I in perimenopause?" or you know you are, but are having a hard time...

The people who keep the weight off long-term aren’t just lucky. They used the quiet to rewire the noise.

Since we know the science, why can't we get generic GLP-1s? It all comes down to the patent and proprietary information.

People love to talk about weight loss wins with GLP-1s like semaglutide or tirzepatide. The before-and-afters are dramatic. But what you don’t see in those pictures? The lean muscle quietly vanishing under the scale’s praise. Unless you're prioritizing the right fuel—especially protein—that loss can be permanent and problematic. It might sound like a scare tactic to get you to eat healthily, but the risks are all too real.

If you’re on a GLP-1 medication like semaglutide or tirzepatide, chances are your stomach has some thoughts about it. Maybe it’s the sudden nausea, the infamous "sulfur burps," or that weirdly full feeling after just a few bites. As more people turn to these meds for weight loss or blood sugar control, a new question is popping up: can probiotics or digestive enzymes help with the GLP-1 side effects?

Despite the science, support, and proven outcomes, people taking these medications still face skepticism, judgment, and flat-out rudeness.

In this guide, we’re cutting through the noise and calling out the most common GLP-1 myths for what they are—subjective and sometimes silly.

My first attempt to get Zepbound through LillyDirect at the discounted price felt like a triangulated game of "Who's On First?" I faced a...

Eli Lilly, the pharmaceutical giant, filed a sweeping set of lawsuits in federal court, accusing four telehealth startups—Mochi Health, Fella Health, Empower Pharmacy, and Henry Meds—of illegally selling off-brand, compounded versions of its blockbuster weight-loss and diabetes drugs, Zepbound and Mounjaro.

The battle over compounded versions of blockbuster weight-loss drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro,...